1. Background {#sec0005}
=============

Acute Viral Bronchiolitis (AVB) is the most common cause of hospitalization among infants during the first 12 months of life [@bib0005]. A variety of viral etiologies are known to cause AVB, particularly the respiratory syncytial virus (RSV) [@bib0010]. The RSV virus has two subtypes, A and B, which occur in different frequencies and combinations each year [@bib0015], [@bib0020]. About 10% of the AVB cases demand hospitalization; mortality rates are 1% or less, mainly in cases with associated co-morbidities [@bib0025]. An effective vaccine is not available; current treatment is only supportive; preventive measures are limited to very expensive monoclonal antibodies [@bib0030]. AVB seems to be correlated with seasonality, gender, gestational birth age, birth weight, breastfeeding, tobacco exposure, crowding, maternal education and viral etiology [@bib0035], [@bib0040], [@bib0045], [@bib0050]. In this study, epidemiologic risk factors, clinical features and viral identification in nasopharyngeal secretion by polymerase chain reaction (PCR) were evaluated and compared in two cohorts (2004 [@bib0055] and 2014) with 314 infants with AVB.

2. Study design {#sec0010}
===============

Descriptive study with a comparison of two cohorts; sample was composed of infants under 12 months of age (for effect of comparison between two cohorts) with AVB and that demanded hospitalization. Patients were attended in a metropolitan region, in public and private hospitals, in a seasonal AVB period for the region (April to September). Diagnosis was based on clinical data, which defines AVB as being the first episode of acute respiratory distress with wheezing, preceded by upper airway symptoms such as rhinorrhea and cough, with or without fever [@bib0005], [@bib0025]. The criterion for severe bronchiolitis was oxygen saturation lower than 92%, which demanded oxygen therapy [@bib0005]. Exclusion criteria were previous episodes of wheezing. A total of 314 patients were selected (2004: 142; 2014: 172). The studies were approved by the Ethical Committee from University of Campinas \[\#076/2003 (2004) and \#00869612.7.0000.5404 (2014)\]. In both cohorts' nasopharyngeal secretions were collected during the first 24 h after hospital admission. In the first cohort, by a washing technique with saline solution followed by aspiration. In the second cohort, collection was done by an aspiration technique without saline solution. Only the described technique for each cohort was accepted. The collected samples were analyzed to viral etiology by Polymerase Chain Reaction (PCR). In the first Cohort, PCR Rt kit (ABI PRISM Big Dye Terminator Cycle Sequencing Ready Reaction kit, Applied Biosystems TM, Foster City, USA) screened RSV and Metapneumovirus [@bib0055]; in the second cohort, Seeplex RV15 ACE detection kit (Seegene, Concord, CA) screened 13 types of RNA viruses and two of DNA viruses: RSV subtypes A and B; rhinovirus A/B/C; parainfluenza virus 1, 2, 3, and 4; adenovirus; coronaviruses 229E/NL63 and OC43; influenza A virus and influenza B virus; bocavirus 1/2/3/4; metapneumovirus; and enterovirus. Epidemiologic data \[gender, age at attendance, seasonality, gestational age, birth weight, breastfeeding, tobacco exposure, crowding (more than 5 people at home) and maternal education\] were analyzed. Clinical data such as previous co-morbidities (lung disease, heart disease, immunodeficiency, undernourishment, Down Syndrome), time of hospitalization, need of mechanical ventilation and death were analyzed and compared in both cohorts. Statistical analysis was performed using the Mann-Whitney, χ^2^ and Fisher Exact tests in the Statistical Package for the Social Sciences software, version 24 (IBM Corp. Released 2015. IBM SPSS Statistics for Windows, Version 24.0. Armonk, NY: IBM Corp.). Adopted value of significance was 5%.

3. Results {#sec0015}
==========

Comparison between epidemiologic data is displayed in [Table 1](#tbl0005){ref-type="table"} ; the 2004 cohort presented lower chances of acquiring of AVB in April (OR = 0.538; 95%CI = 0.298 to 0.922), fewer patients with birth weight under 3000 g (OR = 0.276; 95%CI = 0.153 to 0.485) and gestational age \< 37 weeks (OR = 0.361; 95%CI = 0.187 to 0.695). In the 2004 cohort (3.5 months), median was attendance age higher than in the 2014 cohort (3 months) (P-value = 0.019). Comparison between clinical data can also be seen in [Table 1](#tbl0005){ref-type="table"}. In 2004, there was a higher incidence of previous co-morbidities (OR = 3.653; 95%CI = 1.813 to 7.723). No differences were observed regarding time of hospitalization and need of mechanical ventilation. Deaths occurred only in the 2014 cohort (3 patients). In the 2014 cohort there was: (i) higher RSV identification (OR = 4.769; 95%CI = 2.892 to 7.968); (ii) smaller amount of unidentified samples \[2014: 25/172 (14.53%); 2004: 88/142 (61.97%); OR = 0.105; 95%CI = 0.058 to 0.185)\]; (iii) higher prevalence of RSV-B (OR = 16.05; 95%CI = 0.047 to 34.24) ([Table 2](#tbl0010){ref-type="table"} ). [Table 3](#tbl0015){ref-type="table"} shows the frequency of viral types in the 2004 cohort; [Table 4](#tbl0020){ref-type="table"} shows the frequency of viral types in the 2014 cohort. Metapneumovirus was identified in 5.6% and 1.7% of patients in 2004 and 2014 cohorts, respectively (p = 0.035; OR = 8.817; 95%CI = 1.111 to 4.019).Table 1Epidemiological and clinical data in 2004 and 2014 cohorts of infants with acute viral bronchiolitis.Table 1FeatureGroup2004 (n = 142)2014 (n = 172)Total (n = 314)p-valueOdds ratio95%CISeasonalityApril275380**0.007**[\*](#tblfn0005){ref-type="table-fn"}**0.5280.298** to **0.922**May3955940.5990.340 to 1.047June3535700.7090.344 to 1.454July1619350.3420.111 to 1.006August199280.3610.007 to 3.734September6177.5040.894 to 349SexFemale56701160.908[\*](#tblfn0005){ref-type="table-fn"}0.9490.587 to 1.531Male86102188Reference--Birth weight\< 3000 g237194**\<0.001**[\#](#tblfn0010){ref-type="table-fn"}**0.2760.153** to **0.485**\> 3000 g119101220Reference--Age at attendanceMonths4.47 ± 2.993.76 ± 2.854.08 ± 2.94**0.019**[¥](#tblfn0015){ref-type="table-fn"}3.5 (1--11)3 (0--11)3 (0--11)Gestational age\< 37 weeks144054**0.002**[\#](#tblfn0010){ref-type="table-fn"}**0.3610.187** to **0.695**≥ 37 weeks128132260Reference--Breastfeeding\< 1 month50501000.397[\#](#tblfn0010){ref-type="table-fn"}1.3040.787 to 2.161≥ 1 month92120212Reference--Tobacco exposureYes53491020.116[\#](#tblfn0010){ref-type="table-fn"}1.4830.922 to 2.384No89122211Reference--Number people at home\< 594981920.13[\#](#tblfn0010){ref-type="table-fn"}1.4570.897 to 2.379≥ 54873121Reference--Maternal education\< 5 years3339721[\#](#tblfn0010){ref-type="table-fn"}1.0090.573 to 1.77≥ 5 years109130239ReferencePrevious co-morbiditiesYes351449**\<0.001**[\#](#tblfn0010){ref-type="table-fn"}**3.6531.813** to **0.723**No107157264Reference--Time of hospitalization\< 5 days821041860.646[\#](#tblfn0010){ref-type="table-fn"}0.8940.555 to 1.471≥ 5 days6068128ReferenceMechanical ventilationYes2233550.456[\#](#tblfn0010){ref-type="table-fn"}0.7730.406 to 1.45No120139259ReferenceDeathYes0330.254[\#](#tblfn0010){ref-type="table-fn"}----No142169311----[^1][^2][^3][^4]Table 2Viral identification in nasopharyngeal secretion for RSV, respiratory syncytial virus (RSV) in 2004 and 2014 cohorts of Brazilian Infants with acute viral bronchiolitis.Table 2Identification20042014Totalp-valueOdds ratio95%CIRSV positive47121168 **\<** **0.01**[\#](#tblfn0025){ref-type="table-fn"}**4.7692.892** to **7.968**RSV negative9551146Reference--RSV group A32840**\<0.01**[\*](#tblfn0020){ref-type="table-fn"}0.59450.221 to 1.434RSV group B1389102**16.050.047** to **34.24**RSV ND group12151172Reference--[^5][^6][^7]Table 3Viral identification in nasopharyngeal secretion/frequency of respiratory viruses in 2004 cohort of infants with acute viral bronchiolitis (n = 142).Table 3Viral identificationFrequency (%)None88 (62%)RSV group non determined26 (18.3%)RSV group A13 (9.2%)RSV group B7 (4.9%)Metapneumovirus7 (4.9%)RSV group A + metapneumovirus1 (0.7%)Total142 (100%)[^8]Table 4Viral Identification in nasopharyngeal secretion/frequency of respiratory viruses in 2014 cohort of infants with acute viral bronchiolitis (n = 172).Table 4Viral identification without consider RSV groupsFrequency (%)RSV87 (50.6%)Rhinovirus20 (11.6%)None18 (10.5%)RSV + rhinovirus17 (9.9%)Inconclusive7 (4.1%)RSV + adenovirus4 (2,3%)RSV + hepatitis virus2 (1,2%)RSV + parainfluenza virus type 12 (1.2%)RSV + coronavirus 229 E2 (1.2%)RSV + rinovirus + adenovirus2 (1.2%)Adenovirus1 (0.6%)Influenza A virus1 (0.6%)Parainfluenza virus type 41 (0.6%)Metapneumovirus1 (0.6%)RSV + metapneumovirus1 (0.6%)RSV + influenza A virus1 (0.6%)RSV + bocavirus1 (0.6%)RSV + rhinovirus + metapneumovirus1 (0.6%)RSV + rhinovirus + parainfluenza virus type 11 (0.6%)Coronavirus 229E + parainfluenza virus type 31 (0.6%)Rhinovirus + parainfluenza virus type 41 (0.6%)Total172 (100%)  Viral identification considering RSV groupsFrequency (%)None18 (10.5%)RSV group A66 (38.4%)Other viruses25 (15.1%)RSV group A + other23 (13.4%)RSV group B22 (12.8%)RSV group B + other10 (5.8%)Inconclusive7 (4.1%)Total172 (100%)[^9]

4. Discussion {#sec0020}
=============

Comparison between the cohorts showed similarities for gender, breastfeeding, tobacco exposure, number of people in home (crowding) and maternal education. In both cohorts, there was a greater number of males, which is comparable what is described in literature [@bib0060], [@bib0065]. Conversely, in the first cohort, the age at attendance was slightly higher; both cohorts had a median of under 4 months of age. Around 30% of patients received breastfeeding for at least one month, in both cohorts. Breastfeeding was considered a protective factor for respiratory infections, and is associated with better clinical evolution [@bib0070], [@bib0075], [@bib0080]. Despite stimulus for breastfeeding being on the rise [@bib0085], it is not yet a general behavior. Similarly, tobacco exposure has been associated to some respiratory diseases in infants and children. A Brazilian study with 2037 children under 60 months [@bib0090] demonstrated that 59.89% (1220/2037) had respiratory symptoms. It was clearly higher among children with passive tobacco exposure (65.53%--504/768) compared to no tobacco exposure children (56.42%--716/1269). In our study, there were lower levels of tobacco exposure and crowding in both cohorts; maternal education was mostly more than 5 years. These similarities can be explained by the economic situation in the studied region, considered the richest in the country, with a Human Development Index comparable to some European regions [@bib0095]. In the 2014 cohort, despite some patients coming from private hospitals, it is possible to consider that, in general, all infants had a satisfactory economic condition and similar cultural environment.

AVB prevalence, seasonality, birth weight and gestational age displayed differences between the two cohorts. In the 2014 cohort, there was a higher incidence of AVB in April, more babies with a birth weight \< 3000 g and gestational age \< 37 weeks. Regarding the higher number of AVB cases in April 2014, the fact that both cohorts had higher number of cases occurred in April, May and June (a typical seasonality previously described) has to be taken into account [@bib0055], [@bib0100], [@bib0105]. This difference can be attributed to special weather conditions or a different pattern of virus circulation in 2014. Unfortunately, we don't have national data regarding RSV prevalence in 2004 and 2014 to support this claim. Analyzing gestational age and birth weight together, as they can be considered co-dependents (in general, the lower the gestational age is associated with lower birth weight) a mention to specific facts related to the study region are necessary. Brazil is well-known for its high number of cesarean births; in some private medical services, it can reach more than 50% of births which can result in babies with gestational age and birth weight artificially lower than expected [@bib0110], [@bib0115]. Despite a deeper analysis not being carried out, the higher number of patients with birth weight at birth \< 3000 g and gestational age \< 37 weeks in this second cohort could be explained by the patients from private hospitals. Clinical data were similar in both cohorts regarding time of hospitalization, need of mechanical ventilation and death, also in accordance with literature [@bib0120], [@bib0125]. In the 2004 cohort there were more patients with previous co-morbidities; despite this, no influence was noted in the number of severe cases in this cohort which is the opposite to that described in literature [@bib0125].

On regards to virus analysis, different PCR kits were available at each time [@bib0040], [@bib0055], each with different capacities. The kits used in the 2014 cohort made it possible to identify a wider spectrum of respiratory viruses, isolated or in combination. Different rates of virus identification in both cohorts can be attributed to the use of different kits, despite the same technique being used to identify the viruses (PCR). Nonetheless, the difference between the two cohorts also can be attributed to different prevalence of RSV in each year. Studies have been trying to associate the viral type -- RSV or other respiratory viruses -- with a varying degree of severity in the clinical presentation of AVB. However, the results are still inconclusive [@bib0040], [@bib0050], [@bib0115]. Similar epidemiologic features (gender, breastfeeding, tobacco exposure, crowding and maternal education) could minimize the impact of these possible risk factors in the analysis of cohort comparison. Differences in seasonality, gestational age and birth weight can be attributed to specific natural, cultural and economic conditions that were not deeply analyzed. Previous co-morbidities were more frequent in the 2004 cohort but had no impact on hospitalization time, need for mechanical ventilation or death. These severity features were similar in both cohorts. Viral type was not related to severity in any cohort. Virology and immunology must be considered, studying genetic variants and the maturation of the immune system in AVB by RSV or other viruses, mainly in the response to a virus in its initial phase of life [@bib0120], [@bib0125], [@bib0130], [@bib0135].
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[^1]: Values with positive association are presented in bold. The odds ratio values were based on 2004 cohort. The conditional maximum-likelihood estimate was based on Fisher\'s Exact test.

[^2]: χ^2^ Test.

[^3]: Fisher Test.

[^4]: Mann-Whitney Test; 95%CI, 95% confidence interval.

[^5]: ND, non-determined. The odds ratio values were based on 2014 cohort. The conditional maximum-likelihood estimate was based on Fisher\'s Exact test.

[^6]: χ^2^ test.

[^7]: Fisher test; 95%CI, confidence interval.

[^8]: RSV, respiratory syncytial virus.

[^9]: RSV, respiratory syncytial virus.
